Literature DB >> 7890378

Lymphocyte populations during tuberculosis infection: V beta repertoires.

F Gambón-Deza1, M Pacheco Carracedo, T Cerdá Mota, J Montes Santiago.   

Abstract

The immune response to Mycobacterium tuberculosis is mediated by T lymphocytes. We studied the changes in lymphocyte populations occurring in peripheral blood, pleural fluid, and ascites during tuberculosis infection. For this purpose, we compared recent-onset patients (newly converted to positive Mantoux reactions) with previously diagnosed patients (individuals with organic lesions). Recent infection was associated with peripheral blood lymphocytosis involving T lymphocytes expressing either T-cell receptor alpha/beta or gamma/delta. Lymphocytosis involved both CD4 and CD8 cells. On the other hand, we detected no changes in the distribution of peripheral blood lymphocyte populations in previously diagnosed patients. No changes were found in the numbers of B lymphocytes or natural killer cells in either recently infected or previously diagnosed patients. The pleural effusion and ascitic fluid samples contained T lymphocytes expressing T-cell receptor alpha/beta, the majority of which were CD4+. These lymphocytes showed an inverted CD45RA-to-CD45RO ratio, and we found high-level expression of the interleukin-2 receptor (CD25) in some patients. The results are compatible with the existence of periods of cell activation in the pleural fluid (which are disclosed by the appearance of the CD25 antigen and the transition of CD45RA expression to CD45RO) together with nonactivation periods (loss of CD25 and persistence of CD45RO expression). We studied a fraction of the V beta repertoire in peripheral blood in both groups and the same fraction of the V beta repertoire in pleural fluid from patients with tuberculous pleuritis, demonstrating that, in recently infected subjects, lymphocytosis was produced by the increase in lymphocytes which expressed some specific V beta subfamilies that differed from one individual to another. In two of five patients studied, we found significant changes in the V beta repertoire between lymphocytes from peripheral blood and the pleural fluid samples.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890378      PMCID: PMC173140          DOI: 10.1128/iai.63.4.1235-1240.1995

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  27 in total

1.  Isolation of CD4- CD8- mycobacteria-reactive T lymphocyte clones from rheumatoid arthritis synovial fluid.

Authors:  J Holoshitz; F Koning; J E Coligan; J De Bruyn; S Strober
Journal:  Nature       Date:  1989-05-18       Impact factor: 49.962

2.  Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3.

Authors:  L S Schlesinger; C G Bellinger-Kawahara; N R Payne; M A Horwitz
Journal:  J Immunol       Date:  1990-04-01       Impact factor: 5.422

3.  Sequential appearance of gamma/delta- and alpha/beta-bearing T cells in the peritoneal cavity during an i.p. infection with Listeria monocytogenes.

Authors:  S Ohga; Y Yoshikai; Y Takeda; K Hiromatsu; K Nomoto
Journal:  Eur J Immunol       Date:  1990-03       Impact factor: 5.532

4.  T lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-kilodalton heat shock protein.

Authors:  M E Munk; B Schoel; S Modrow; R W Karr; R A Young; S H Kaufmann
Journal:  J Immunol       Date:  1989-11-01       Impact factor: 5.422

5.  Early appearing gamma/delta-bearing T cells during infection with Calmétte Guérin bacillus.

Authors:  T Inoue; Y Yoshikai; G Matsuzaki; K Nomoto
Journal:  J Immunol       Date:  1991-04-15       Impact factor: 5.422

6.  Preferential expansion of Ly-1 B and CD4- CD8- T cells in the polyclonal lymphocyte responses to murine T. cruzi infection.

Authors:  P Minoprio; A Bandeira; P Pereira; T Mota Santos; A Coutinho
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

7.  The T cell receptors of human gamma delta T cells reactive to Mycobacterium tuberculosis are encoded by specific V genes but diverse V-J junctions.

Authors:  J D Ohmen; P F Barnes; K Uyemura; S Z Lu; C L Grisso; R L Modlin
Journal:  J Immunol       Date:  1991-11-15       Impact factor: 5.422

8.  Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis.

Authors:  E M Janis; S H Kaufmann; R H Schwartz; D M Pardoll
Journal:  Science       Date:  1989-05-12       Impact factor: 47.728

9.  Late dominance of the inflammatory process in murine influenza by gamma/delta + T cells.

Authors:  S R Carding; W Allan; S Kyes; A Hayday; K Bottomly; P C Doherty
Journal:  J Exp Med       Date:  1990-10-01       Impact factor: 14.307

10.  A large fraction of human peripheral blood gamma/delta + T cells is activated by Mycobacterium tuberculosis but not by its 65-kD heat shock protein.

Authors:  D Kabelitz; A Bender; S Schondelmaier; B Schoel; S H Kaufmann
Journal:  J Exp Med       Date:  1990-03-01       Impact factor: 14.307

View more
  10 in total

1.  Dynamic changes in circulating and antigen-responsive T-cell subpopulations post-Mycobacterium bovis infection in cattle.

Authors:  J M Pollock; D A Pollock; D G Campbell; R M Girvin; A D Crockard; S D Neill; D P Mackie
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

2.  Immunization of volunteers with Salmonella enterica serovar Typhi strain Ty21a elicits the oligoclonal expansion of CD8+ T cells with predominant Vbeta repertoires.

Authors:  Rosângela Salerno-Gonçalves; Rezwanul Wahid; Marcelo B Sztein
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

3.  Mycobacterium tuberculosis induces apoptosis in gamma/delta T lymphocytes from patients with advanced clinical forms of active tuberculosis.

Authors:  R Duarte; J M Kindlelán; J Carracedo; P Sánchez-Guijo; R Ramírez
Journal:  Clin Diagn Lab Immunol       Date:  1997-01

4.  In vitro expansion of T-cell-receptor Valpha2.3(+) CD4(+) T lymphocytes in HLA-DR17(3), DQ2(+) individuals upon stimulation with Mycobacterium tuberculosis.

Authors:  S Esin; G Batoni; G Saruhan-Direskeneli; R A Harris; J Grunewald; M Pardini; S B Svenson; M Campa; H Wigzell
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

5.  TCR repertoire, clonal dominance, and pulmonary trafficking of mycobacterium-specific CD4+ and CD8+ T effector cells in immunity against tuberculosis.

Authors:  George Du; Crystal Y Chen; Yun Shen; Liyou Qiu; Dan Huang; Richard Wang; Zheng W Chen
Journal:  J Immunol       Date:  2010-08-30       Impact factor: 5.422

Review 6.  The CD4+/CD8+ Ratio in Pulmonary Tuberculosis: Systematic and Meta-Analysis Article.

Authors:  Yongmei Yin; Jie Qin; Yaping Dai; Fanwei Zeng; Hao Pei; Jun Wang
Journal:  Iran J Public Health       Date:  2015-02       Impact factor: 1.429

Review 7.  Alcohol's Effects on Lung Health and Immunity.

Authors:  Samantha M Simet; Joseph H Sisson
Journal:  Alcohol Res       Date:  2015

8.  Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis.

Authors:  Christian Lundtoft; Anthony Afum-Adjei Awuah; Jens Rimpler; Kirstin Harling; Norman Nausch; Malte Kohns; Ernest Adankwah; Franziska Lang; Laura Olbrich; Ertan Mayatepek; Ellis Owusu-Dabo; Marc Jacobsen
Journal:  PLoS Pathog       Date:  2017-06-05       Impact factor: 6.823

9.  Analysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection.

Authors:  Nadia Caccamo; Giuliana Guggino; Serena Meraviglia; Giuseppe Gelsomino; Paola Di Carlo; Lucina Titone; Marialuisa Bocchino; Domenico Galati; Alessandro Matarese; Jan Nouta; Michel R Klein; Alfredo Salerno; Alessandro Sanduzzi; Francesco Dieli; Tom H M Ottenhoff
Journal:  PLoS One       Date:  2009-05-13       Impact factor: 3.240

10.  Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin in patients with tuberculous pleuritis.

Authors:  A Hamzaoui; K Hamzaoui; A Kahan; A Chabbou
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.